Aspira Pathlab & Diagnostics Valuation

Q: What is the Fair Price of 540788 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

540788 (₹66) is trading above our estimate of [[fair value]] (₹18.12)

Is 540788 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 540788 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 540788 (₹66) is trading above our estimate of fair value (₹18.12)

Significantly Below Fair Value: 540788 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 540788?

Key metric: As 540788 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 540788. This is calculated by dividing 540788's market cap by their current revenue.
What is 540788's PS Ratio?
PS Ratio	4.5x
Sales	₹152.38m
Market Cap	₹679.34m

540788 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.5x
Enterprise Value/EBITDA	-218.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 540788's PS Ratio compare to its peers?

The above table shows the PS ratio for 540788 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.2x
526301 Medinova Diagnostic Services	4.1x	n/a	₹403.9m
516110 Family Care Hospitals	1.5x	n/a	₹364.1m
NIDAN Nidan Laboratories and Healthcare	1.8x	n/a	₹404.5m
542918 Gian Life Care	1.6x	n/a	₹196.6m
540788 Aspira Pathlab & Diagnostics	4.5x	n/a	₹679.3m

Price-To-Sales vs Peers: 540788 is expensive based on its Price-To-Sales Ratio (4.5x) compared to the peer average (2.2x).

Price to Sales Ratio vs Industry

How does 540788's PS Ratio compare vs other companies in the IN Healthcare Industry?

9 Companies	Price / Sales	Estimated Growth	Market Cap
MONOPHARMA Mono Pharmacare	0.5x	n/a	US$7.29m
539938 Medico Intercontinental	0.7x	n/a	US$7.02m
542934 Chandra Bhagat Pharma	0.3x	n/a	US$6.17m
530697 Zenlabs Ethica	0.5x	n/a	US$3.12m

9 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 540788 is expensive based on its Price-To-Sales Ratio (4.5x) compared to the Indian Healthcare industry average (4.1x).

Price to Sales Ratio vs Fair Ratio

What is 540788's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

540788 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	4.5x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 540788's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

28.6%

-37.0%

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

-2.7%

-2.5%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

n/a